Schwerta is levamlodipine benzenesulfonate, and tilmisartan two drugs have a lowering effect on both high and low pressure. Levamlodipine benzenesulfonate is a calcium antagonist, mainly through the dilation of peripheral vasculature to reduce blood pressure, systolic diastolic blood pressure have a lowering effect. Timosartan is an antihypertensive drug that inhibits angiotensin II receptors and has effects on both systolic and diastolic blood pressure. Levamlodipine besylate and Timosartan are commonly used antihypertensive drugs with stable antihypertensive effects, and there are no drugs specifically targeting systolic or diastolic blood pressure in the clinic. Adverse reactions of levamlodipine benzenesulfonate include headache, flushing, palpitations, lower limb edema, etc. Hypotension, cardiogenic shock, and patients with allergy to drug components are prohibited. Adverse reactions to temesartan: upper respiratory tract infection, cough, abdominal pain, nausea, low back pain, etc. It is contraindicated in patients who are allergic to the components of the drug, pregnant and breastfeeding women, and patients with severe renal impairment. Note that the use of medication should be carried out under the guidance of a professional physician, and should not be used without authorization.